Lloyd Advisory Services’s bluebird bio BLUE Stock Holding History

Lloyd Advisory Services’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	122
2022 Q1	$0	Buy	+3	New	+$396	﹤0.01%	603

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lloyd Advisory Services's BLUE Position: Q2 2022 in Review

Lloyd Advisory Services sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 3 shares.

Lloyd Advisory Services first reported a position in BLUE in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

Lloyd Advisory Services reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
Lloyd Advisory Services sold 3 bluebird bio shares in Q2 2022.
Lloyd Advisory Services first reported a position in bluebird bio in Q1 2022 and held it in 1 quarter.
Lloyd Advisory Services's bluebird bio position peaked at $0 in Q1 2022.
151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Lloyd Advisory Services's 13F filing for Q2 2022, filed 15 Aug 2022.